Article
DNA methylation biomarkers for the diagnosis and treatment management of breast cancer: where are we now?
21 Aug 2025
Abstract excerpt
Breast cancer is one of the most commonly diagnosed cancers worldwide and is a significant contributor to the global cancer burden. It is a clinically heterogeneous disease and reliable tools are needed to support treatment decisions, including patient risk, prediction of therapeutic response and monitoring patients throughout their cancer journey. DNA methylation alterations are an early occurring, highly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
